Cell and Gene Therapies

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Perales, Miguel-Angel (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Abutalib, Syed A. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Bollard, Catherine (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2019.
• Έκδοση: 1st ed. 2019.
• Σειρά: Advances and Controversies in Hematopoietic Transplantation and Cell Therapy,
• Θέματα: Hematology.; Oncology .; Oncology.

In this book, experts in the field express their well-reasoned opinions on a range of complex, clinically relevant issues across the full spectrum of cell and gene therapies with the aim of providing trainee and practicing hematologists, including hematopoietic transplant physicians, with informatio...

Πίνακας περιεχομένων:

• Historical perspective and current focus
• Part I: Genetically modified T cells (Chimeric antigen receptors and T cell receptors): Chimeric antigen receptor-T cells: Antigen selection, CAR development and future prospects
• Chimeric antigen receptor-T cells for leukemias in children: Methods, data and challenges
• Chimeric antigen receptor-T cells for leukemias in adults- Methods, data and challenges
• Chimeric antigen receptor-T cells for lymphomas: Methods, data and challenges
• T-cell receptors-gene modified T-cells for cancer
• Methods, data and challenges.
• Part II: Beyond chimeric antigen receptor and T-cell receptors - Data, Consensus & Challenges: Cytotoxic T cells for infections: From donor-specific to "off the shelf"
• Donor lymphocyte infusion in different transplant settings: When and how?- T-regulatory cells: Broadening applicability
• Tumor infiltrating lymphocytes: Current concepts and practices
• Part III: Beyond T-cells: Natural killer cells: What have we learned?- Dendritic cells in hematopoietic cell transplantation
• Mesenchymal stem cells: From bench to bedside and back
• Cell Therapies: Regulatory concerns and data collection
• Part IV: Gene Therapy: Gene therapy for hematologic malignancies and in transplant setting
• Gene therapy for nonmalignant disorders
• Future prospects of cell and gene therapies.